Monday, April 21, 2025
12:00PM – 1:00PM ET
Please note this TeleECHO program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
PRESENTING FACULTY & PROGRAM CHAIR
 |
Michael R. Grunwald, MD, FACP Chief, Leukemia Division Director, Transplantation and Cellular Therapy Program Department of Hematologic Oncology and Blood Disorders Levine Cancer Institute Atrium Health Charlotte, North Carolina |
PROGRAM OVERVIEW
This interactive TeleECHO program seeks to help healthcare practitioners involved in the management of patients with AML to better: select guideline-recommended molecular testing and apply results to treatment strategies; personalize treatment based on disease- and patient specific-factors; recognize, prevent, and manage adverse effects of CLL or AML treatment; and apply shared decision-making when communicating treatment options with patients.
TARGET AUDIENCE
This multi-modular educational initiative is intended for US-based community medical oncologists, and other healthcare providers involved in the management of patients with AML.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to
- Summarize key best practices in genomic and molecular assessment of AML to ensure optimized clinical assessment in the community oncology setting
- Assess clinical updates informing management of newly diagnosed and relapsed/refractory AML through interpretation of disease- and patient-specific factors
- Describe best practices in the assessment and monitoring of potential adverse events in AML to optimize care
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture the faculty may mention the use of medications for both US Food and Drug Administration (FDA)-approved and non-FDA-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
